Galaj, Ewa
Hempel, Briana
Moore, Allamar
Klein, Benjamin
Bi, Guo-Hua
Gardner, Eliot L.
Seltzman, Herbert H.
Xi, Zheng-Xiong
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (DA000633-01)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (DA000633-01)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (DA000633-01)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (DA-000633-01)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (DA000633-01)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (DA000633-01)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (DA000633-01)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (DA000633-01)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
Article History
Received: 3 February 2022
Revised: 21 June 2022
Accepted: 4 July 2022
First Online: 18 July 2022
Competing interests
: The authors declare no competing interests.